title: Tamoxifen-related vasculitis.
authors.affiliation: Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: Mauricio Z
authors.initials: MZ
authors.lastname: Baptista
authors.forename: Victor G
authors.initials: VG
authors.lastname: Prieto
authors.forename: Susan
authors.initials: S
authors.lastname: Chon
authors.forename: Gabriel N
authors.initials: GN
authors.lastname: Hortobagyi
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Esteva
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy; D020847:Estrogen Receptor Modulators / Q000009:adverse effects; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D012867:Skin / Q000098:blood supply / Q000187:drug effects*; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects*; D014657:Vasculitis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D018931:Antineoplastic Agents, Hormonal; D050071:Bone Density Conservation Agents; D020847:Estrogen Receptor Modulators; D013629:Tamoxifen